Profile
Full Name
Akebia Therapeutics, Inc.Ticker Symbol
AKBAExchange
NASDAQSector
HealthcareCountry
United StatesIPO
March 20, 2014Indexes
Not includedWebsite
http://www.akebia.comEmployees
181Key Details
Price
$1.65(+6.45%)
Market cap
$431.03M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$160.18M(-17.70% YoY)
Annual EPS
-$0.33(-17.86% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Akebia Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 4, 25 HC Wainwright & Co.
BuyApr 1, 25 Jefferies
BuyMar 14, 25 Piper Sandler
OverweightMar 14, 25 HC Wainwright & Co.
BuyJan 23, 25 HC Wainwright & Co.
BuyJan 14, 25 HC Wainwright & Co.
BuyOct 23, 24 HC Wainwright & Co.
BuyOct 10, 24 HC Wainwright & Co.
BuyOct 8, 24 HC Wainwright & Co.
BuySep 6, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Akebia Therapeutics?
- Does Akebia Therapeutics pay dividends?
- What sector is Akebia Therapeutics in?
- What industry is Akebia Therapeutics in?
- What country is Akebia Therapeutics based in?
- When did Akebia Therapeutics go public?
- Is Akebia Therapeutics in the S&P 500?
- Is Akebia Therapeutics in the NASDAQ 100?
- Is Akebia Therapeutics in the Dow Jones?
- When was Akebia Therapeutics's last earnings report?
- When does Akebia Therapeutics report earnings?
- Should I buy Akebia Therapeutics stock now?
What is the ticker symbol for Akebia Therapeutics?
The ticker symbol for Akebia Therapeutics is NASDAQ:AKBA
Does Akebia Therapeutics pay dividends?
No, Akebia Therapeutics does not pay dividends
What sector is Akebia Therapeutics in?
Akebia Therapeutics is in the Healthcare sector
What industry is Akebia Therapeutics in?
Akebia Therapeutics is in the Drug Manufacturers - Specialty & Generic industry
What country is Akebia Therapeutics based in?
Akebia Therapeutics is headquartered in United States
When did Akebia Therapeutics go public?
Akebia Therapeutics's initial public offering (IPO) was on March 20, 2014
Is Akebia Therapeutics in the S&P 500?
No, Akebia Therapeutics is not included in the S&P 500 index
Is Akebia Therapeutics in the NASDAQ 100?
No, Akebia Therapeutics is not included in the NASDAQ 100 index
Is Akebia Therapeutics in the Dow Jones?
No, Akebia Therapeutics is not included in the Dow Jones index
When was Akebia Therapeutics's last earnings report?
Akebia Therapeutics's most recent earnings report was on Mar 13, 2025
When does Akebia Therapeutics report earnings?
The next expected earnings date for Akebia Therapeutics is May 9, 2025
Should I buy Akebia Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions